Development of a cytomegalovirus vector for somatic gene therapy

Bone Marrow Transplantation

Volumn 25, Issue , 2000, Pages S80-S82

  Borst, E ^a   Messerle, M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cytomegalovirus; Gene therapy; Tropism; Vector development

Indexed keywords

VIRUS VECTOR;

CONFERENCE PAPER; GENE THERAPY; GENE TRANSFER; HUMAN CYTOMEGALOVIRUS; MOLECULAR CLONING; PRIORITY JOURNAL; TARGET CELL; VIRUS GENOME;

CYTOMEGALOVIRUS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LUMINESCENT PROTEINS; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC;

EID: 0033935033     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702361     Document Type: Article

References (13)

1. Britt WJ, Alford CA. Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM (eds). Fields Virology, 3rd edn. Lippincott-Raven Publishers: Philadelphia, 1996, pp 2493-2523.
2. Plotkin SA, Smiley ML, Friedman HM et al. Towne-vaccineinduced prevention of cytomegalovirus disease after renal transplants. Lancet 1984; 1: 528-530.
3. Plotkin SA, Higgins R, Kurtz JB et al. Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients. Transplantation 1994; 58: 1176-1178.
4. Sinzger C, Jahn G. Human cytomegalovirus cell tropism and pathogenesis. Intervirology 1996; 39: 302-319.
5. von Laer D, Meyer-Koenig U, Serr A et al. Detection of cytomegalovirus DNA in CD34 cells from blood and bone marrow. Blood 1995; 86: 4086-4090.
6. Mendelson M, Monard S, Sissons P, Sinclair J. Detection of endogenous human cytomegalovirus in CD34 bone marrow progenitors. J Gen Virol 1996; 77: 3099-3102.
7. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 1998; 95: 3937-3942.
8. Chee MS, Bankier AT, Beck S et al. Analysis of the proteincoding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 1990; 154: 125-169.
9. Hengel H, Brune W, Koszinowski UH. Immune evasion by cytomegalovirus-survival strategies of a highly adapted opportunist. Trends Microbiol 1998; 6: 190-197.
10. Messerle M, Crnkovic I, Hammerschmidt W et al. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci USA 1997; 94: 14759-14763.
11. Borst E, Hahn G, Koszinowski UH, Messerle M. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J Virol 1999; 73: 8320-8329.
12. Pósfai G, Koob MD, Kirkpatrick HA, Blattner FR. Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome. J Bacteriol 1997; 179: 4426-4428.
13. Prasher DC. Using GFP to see the light. Trends Genet 1995; 11: 320-323.